Milatuzumab
Jump to navigation
Jump to search
Milatuzumab | |
---|---|
Term | Milatuzumab |
Short definition | Milatuzumab - (pronounced) (MIH-luh-TOO-zoo-mab) A substance being studied for the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other cell types. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Milatuzumab - (pronounced) (MIH-luh-TOO-zoo-mab) A substance being studied for the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other cell types. It can help kill cancer cells. Milatuzumab is a type of monoclonal antibody. Also called hLL1 and IMMU-110
External links
- Medical encyclopedia article on Milatuzumab
- Wikipedia's article - Milatuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski